Aliases & Classifications for Atherosclerosis

Summaries for Atherosclerosis

MedlinePlus : 41 atherosclerosis is a disease in which plaque builds up inside your arteries. plaque is a sticky substance made up of fat, cholesterol, calcium, and other substances found in the blood. over time, plaque hardens and narrows your arteries. that limits the flow of oxygen-rich blood to your body. atherosclerosis can lead to serious problems, including coronary artery disease. these arteries supply blood to your heart. when they are blocked, you can suffer angina or a heart attack. carotid artery disease. these arteries supply blood to your brain. when they are blocked you can suffer a stroke. peripheral arterial disease. these arteries are in your arms, legs and pelvis. when they are blocked, you can suffer from numbness, pain and sometimes infections. atherosclerosis usually doesn't cause symptoms until it severely narrows or totally blocks an artery. many people don't know they have it until they have a medical emergency. a physical exam, imaging, and other diagnostic tests can tell if you have it. medicines can slow the progress of plaque buildup. your doctor may also recommend procedures such as angioplasty to open the arteries, or surgery on the coronary or carotid arteries. lifestyle changes can also help. these include following a healthy diet, getting regular exercise, maintaining a healthy weight, quitting smoking, and managing stress. nih: national heart, lung, and blood institute

MalaCards based summary : Atherosclerosis, also known as arteriosclerosis, is related to limb ischemia and myocardial infarction, and has symptoms including angina pectoris, chest pain and edema. An important gene associated with Atherosclerosis is SELE (Selectin E), and among its related pathways/superpathways are Cytokine Signaling in Immune system and Blood-Brain Barrier and Immune Cell Transmigration: VCAM-1/CD106 Signaling Pathways. The drugs Olmesartan and Methyltestosterone have been mentioned in the context of this disorder. Affiliated tissues include Endothelium and Heart, and related phenotypes are Decreased free cholesterol and cardiovascular system

Wikipedia : 71 Atherosclerosis (also known as arteriosclerotic vascular disease or ASVD) is a specific form of... more...

Related Diseases for Atherosclerosis

Diseases related to Atherosclerosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 402)
id Related Disease Score Top Affiliating Genes
1 limb ischemia 29.9 APOE ICAM1 NOS3 TNF
2 myocardial infarction 29.8 AGER APOE CCL2 HMGCR ICAM1 LPA
3 cerebral atherosclerosis 12.3
4 aortic atherosclerosis 12.2
5 generalized atherosclerosis 12.2
6 atherosclerosis, premature, with deafness, nephropathy, diabetes mellitus, photomyoclonus, and degenerative neurologic disease 11.8
7 renal artery atheroma 11.4
8 arteriosclerosis 11.2
9 peripheral vascular disease 11.1
10 cerebrotendinous xanthomatosis 11.1
11 binswanger's disease 11.1
12 sitosterolemia 11.1
13 werner syndrome 11.1
14 coronary artery disease 11.1
15 vascular disease 11.0
16 hypertriglyceridemia 11.0
17 diffuse dermal angiomatosis 11.0
18 carotid artery disease 11.0
19 hepatic lipase deficiency 11.0
20 carotid stenosis 10.9
21 plasminogen activator inhibitor-1 deficiency 10.9
22 feigenbaum bergeron richardson syndrome 10.9
23 subcortical arteriosclerotic encephalopathy 10.8
24 hypercholesterolemia, familial 10.8
25 dementia - subcortical 10.8
26 wolman disease 10.6
27 familial lcat deficiency 10.6
28 nestor-guillermo progeria syndrome 10.6
29 hyperlipidemia type 3 10.6
30 clopidogrel resistance 10.6
31 peripheral arterial occlusive disease 1 10.6
32 aortic aneurysm, familial thoracic 1 10.6
33 lipodystrophy, familial partial, 2 10.6
34 prinzmetal's variant angina 10.6
35 congenital analbuminemia 10.6
36 pseudoxanthoma elasticum 10.6
37 intracranial arteriosclerosis 10.6
38 vascular myelopathy 10.6
39 hyperlipoproteinemia, type ib 10.6
40 central retinal artery occlusion 10.6
41 endotheliitis 10.5
42 cerebritis 10.4
43 cetp-related hyperalphalipoproteinemia 10.4 APOE PPARG SELE
44 hypopyon ulcer 10.4 ICAM1 SELE VCAM1
45 macrodactyly of the foot 10.4 ICAM1 SELE VCAM1
46 right atrium familial dilatation 10.4 MMP3 MMP9
47 skin squamous cell carcinoma 10.4 APOE HMGCR LPA
48 asphyxia neonatorum 10.4 ABCG8 APOE LPA
49 periosteal chondrosarcoma 10.4 ICAM1 SELE VCAM1
50 glutathionuria 10.4 MMP3 NOS3 SELE

Graphical network of the top 20 diseases related to Atherosclerosis:



Diseases related to Atherosclerosis

Symptoms & Phenotypes for Atherosclerosis

UMLS symptoms related to Atherosclerosis:


angina pectoris, chest pain, edema

GenomeRNAi Phenotypes related to Atherosclerosis according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased free cholesterol GR00340-A-2 8.92 ABCG8 APOE HMGCR LPA

MGI Mouse Phenotypes related to Atherosclerosis:

44 (show all 11)
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.32 AGER ALOX5 APOE ICAM1 MMP9 MSR1
2 homeostasis/metabolism MP:0005376 10.32 ABCG8 AGER ALOX5 APOE HMGCR ICAM1
3 cellular MP:0005384 10.27 NOS3 PON3 PPARD PPARG SELE TNF
4 hematopoietic system MP:0005397 10.22 AGER ALOX5 APOE ICAM1 MMP3 MMP9
5 immune system MP:0005387 10.22 APOE CCL2 ICAM1 MMP3 MMP9 MSR1
6 growth/size/body region MP:0005378 10.21 AGER APOE HMGCR ICAM1 MMP9 NOS3
7 adipose tissue MP:0005375 10.04 PPARD PPARG TNF ALOX5 APOE NOS3
8 integument MP:0010771 9.91 AGER APOE ICAM1 MMP9 PON3 PPARD
9 liver/biliary system MP:0005370 9.81 ABCG8 APOE HMGCR NOS3 PON3 PPARD
10 muscle MP:0005369 9.61 AGER APOE ICAM1 MMP9 NOS3 OLR1
11 skeleton MP:0005390 9.28 AGER ALOX5 APOE MMP3 MMP9 NOS3

Drugs & Therapeutics for Atherosclerosis

Drugs for Atherosclerosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 732)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Olmesartan Approved, Investigational Phase 4,Phase 3,Phase 2 144689-24-7, 144689-63-4 158781 130881
2
Methyltestosterone Approved Phase 4 58-18-4 6010
3
Testosterone Approved, Investigational Phase 4 58-22-0 6013
4
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-78-2 2244
5
Enalapril Approved, Vet_approved Phase 4 75847-73-3 5362032 40466924
6
Enalaprilat Approved Phase 4 76420-72-9 6917719
7
Rimonabant Approved, Investigational Phase 4,Phase 3 168273-06-1, 158681-13-1 104850
8
Simvastatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 79902-63-9 54454
9
Fluvastatin Approved Phase 4,Phase 3,Phase 2 93957-54-1 1548972
10
Pioglitazone Approved, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1 111025-46-8 4829
11
Zinc Approved Phase 4,Phase 3,Phase 2 7440-66-6 32051 23994
12
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
13
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3,Phase 2 128794-94-5 5281078
14
Mycophenolic acid Approved Phase 4,Phase 3,Phase 2 24280-93-1 446541
15
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Early Phase 1 50-28-2 5757 53477783
16
Progesterone Approved, Vet_approved Phase 4,Phase 3,Phase 2 57-83-0 5994
17
Cilostazol Approved Phase 4,Phase 3,Phase 2,Phase 1 73963-72-1 2754
18
Probucol Approved Phase 4,Phase 2 23288-49-5 4912
19
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
20
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
21
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
22
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
23
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
24
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 3 79217-60-0, 59865-13-3 5284373 6435893
25
Etanercept Approved, Investigational Phase 4,Phase 2 185243-69-0
26
Ustekinumab Approved, Investigational Phase 4 815610-63-0
27
Cyproterone Acetate Approved, Investigational Phase 4 427-51-0
28
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
29
Metformin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 657-24-9 14219 4091
30
Acarbose Approved, Investigational Phase 4,Phase 3 56180-94-0 441184
31
Ezetimibe Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 163222-33-1 150311
32
Tacrolimus Approved, Investigational Phase 4,Phase 3 104987-11-3 445643 439492
33
Lopinavir Approved Phase 4 192725-17-0 92727
34
Ritonavir Approved, Investigational Phase 4 155213-67-5 392622
35
Bisoprolol Approved Phase 4 66722-44-9 2405
36
Candesartan Approved Phase 4,Phase 3 139481-59-7 2541
37
Diltiazem Approved Phase 4,Phase 3,Phase 1 42399-41-7 39186
38
Paclitaxel Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 33069-62-4 36314
39
Adalimumab Approved Phase 4,Phase 3 331731-18-1 16219006
40
Dimethyl fumarate Approved, Investigational Phase 4 624-49-7 637568 5271565
41
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1 55142-85-3 5472
42
Nitric Oxide Approved Phase 4,Phase 2 10102-43-9 145068
43
Bupivacaine Approved, Investigational Phase 4,Phase 2,Phase 3 2180-92-9, 38396-39-3 2474
44
Clonidine Approved Phase 4 4205-90-7 2803
45
Levobupivacaine Approved Phase 4 27262-47-1 92253
46
Morphine Approved, Investigational Phase 4 57-27-2 5288826
47
Adenosine Approved, Investigational Phase 4,Phase 2,Phase 3 58-61-7 60961
48
Menthol Approved Phase 4,Phase 2,Phase 3 2216-51-5 16666
49
Nebivolol Approved, Investigational Phase 4,Phase 3 152520-56-4, 99200-09-6, 118457-14-0 71301
50
Losartan Approved Phase 4,Early Phase 1 114798-26-4 3961

Interventional clinical trials:

(show top 50) (show all 2478)
id Name Status NCT ID Phase
1 The Study of the Effects of Vitamin A on Immune System in Patients With Atherosclerosis Unknown status NCT00963222 Phase 4
2 Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT) Unknown status NCT02360956 Phase 4
3 Testosterone Replacement in Older Men and Atherosclerosis Progression Unknown status NCT00287586 Phase 4
4 Homocysteine Lowering and Atherosclerosis Reduction Trial (HART) Unknown status NCT00217178 Phase 4
5 Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases. Unknown status NCT00734123 Phase 4
6 Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume Unknown status NCT01382277 Phase 4
7 Fluvastatin AmelIorates aTHerosclerosis Study Unknown status NCT01681199 Phase 4
8 The Effect of Vitamin A on Atherosclerosis Unknown status NCT01414972 Phase 4
9 Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic Lesions Unknown status NCT00640744 Phase 4
10 The Effect of a Natural Polyphenolic Extract From Pomegrnate (POMX) on the Development of Atherosclerosis in Diabetic Patients Unknown status NCT00470808 Phase 4
11 The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques Unknown status NCT01773512 Phase 4
12 Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients Unknown status NCT00155350 Phase 4
13 Type 2 Diabetes Mellitus and Atherosclerosis Unknown status NCT01250340 Phase 4
14 Comparison of Stenting Versus Best Medical Therapy for Treatment of Ostial Renal Artery Stenosis: a Trial in Patients With Advanced Atherosclerosis Unknown status NCT00711984 Phase 4
15 Does Rosuvastatin Delay Progression of Atherosclerosis in HIV Unknown status NCT01813357 Phase 4
16 Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients Unknown status NCT00247494 Phase 4
17 Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT) Unknown status NCT00712049 Phase 4
18 Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH) Unknown status NCT00885872 Phase 4
19 Kronos Early Estrogen Prevention Study (KEEPS) Unknown status NCT00154180 Phase 4
20 To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Unknown status NCT02098460 Phase 4
21 The Effect of Dates on Plasma Lipids, Oxidative Stress and the Atherogenicity of Serum in Healthy Adults Unknown status NCT00750789 Phase 4
22 Erythrocyte-Mediated Drug Delivery for the Prevention of Stent Restenosis Unknown status NCT00484965 Phase 4
23 Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease Unknown status NCT01653600 Phase 4
24 Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial Unknown status NCT00500279 Phase 4
25 Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging Unknown status NCT00920101 Phase 4
26 Assessment of Stent Strut Coverage and Endothelial Function After Drug-Eluting Stents Unknown status NCT01073111 Phase 4
27 The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients Unknown status NCT00247507 Phase 4
28 CYPRESS - CYPHER for Evaluating Sustained Safety Unknown status NCT00954707 Phase 4
29 Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc) Unknown status NCT00736463 Phase 4
30 Testosterone for Peripheral Vascular Disease Unknown status NCT00504712 Phase 4
31 Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol Level Unknown status NCT00866229 Phase 4
32 Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis Unknown status NCT02144857 Phase 4
33 PCOS, Therapy and Markers of Cardiovascular Risk Unknown status NCT01798875 Phase 4
34 Study Effects of Ginkgo Biloba Extract on Endothelial Cell Function and Genetic Effects on the Response to Ginkgo Biloba Extract in Diabetic Patients With Stable Coronary Artery Disease Unknown status NCT01038050 Phase 4
35 Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial) Unknown status NCT00858676 Phase 4
36 Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease Unknown status NCT00188188 Phase 4
37 Pioglitazone Vs Placebo in Combination With Niacin Extended Release on Low HDL Unknown status NCT00300365 Phase 4
38 Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial Unknown status NCT00120978 Phase 4
39 Far Infrared Therapy on Peripheral Artery Disease in Hemodialysis Patients Unknown status NCT01095549 Phase 4
40 Effects of DES Platforms on Markers of Endothelial Damage and Inflammation Unknown status NCT01489202 Phase 4
41 Atorvastatin Plus Ezetimibe on Coronary Plaque Progression Unknown status NCT01086020 Phase 4
42 Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure Unknown status NCT00716573 Phase 4
43 RAltegravir Switch STudy: Effects on Endothelial Recovery Unknown status NCT01453933 Phase 4
44 Comparison of Vascular Remodeling Between Different Antianginal Medication Evaluated by Noninvasive ECG-gated Fundus Photographic Evaluation Unknown status NCT01162902 Phase 4
45 Assessment of Surface Coverage of Two Types of DES in Diabetes Mellitus and Non- Diabetes Mellitus Unknown status NCT01023919 Phase 4
46 Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT Unknown status NCT01021930 Phase 4
47 Curcumin for Type 2 Diabetic Patients Unknown status NCT01052597 Phase 4
48 Effects of Raltegravir Based Regimen on Platelet Reactivity, Platelet-monocyte Aggregation and Immune Activation Unknown status NCT02383355 Phase 4
49 Safety and Effectiveness of the Coronary Momo Stent Unknown status NCT01535625 Phase 4
50 The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis Unknown status NCT01088165 Phase 4

Search NIH Clinical Center for Atherosclerosis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: atherosclerosis

Genetic Tests for Atherosclerosis

Genetic tests related to Atherosclerosis:

id Genetic test Affiliating Genes
1 Atherosclerosis 29

Anatomical Context for Atherosclerosis

MalaCards organs/tissues related to Atherosclerosis:

39
Endothelial, Heart, Smooth Muscle, Monocytes, Kidney, Brain, Testes
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Atherosclerosis:
id Tissue Anatomical CompartmentCell Relevance
1 Endothelium Arteries Arterial Endothelial Cells Affected by disease
2 Heart Coronary Capillary Plexus Affected by disease
3 Heart Coronary Vessels Affected by disease

Publications for Atherosclerosis

Articles related to Atherosclerosis:

(show top 50) (show all 4989)
id Title Authors Year
1
Impact of Morning Onset on the Incidence of Recurrent Acute Coronary Syndrome and Progression of Coronary Atherosclerosis in Acute Myocardial Infarction. ( 28090071 )
2017
2
CD4(+)CD28(null) T Cells are related to previous cytomegalovirus infection but not to accelerated atherosclerosis in ANCA-associated vasculitis. ( 28084533 )
2017
3
Killing the old: cell senescence in atherosclerosis. ( 28079111 )
2017
4
Atherosclerosis of aberrant arteries from the left gastric artery into the right intralobar pulmonary sequestration complicated by mycobacterial epithelioid cell granuloma. ( 27776258 )
2017
5
GSTM1 polymorphism in patients with clinical manifestations of atherosclerosis. ( 28362975 )
2017
6
MicroRNA-181b Controls Atherosclerosis and Aneurysms Through Regulation of TIMP-3 and Elastin. ( 27756793 )
2017
7
Aortic Atherosclerosis Determines Increased Retrograde Blood Flow as a Potential Mechanism of Retrograde Embolic Stroke. ( 28049202 )
2017
8
Asialoglycoprotein receptors as important mediators of plasma lipids and atherosclerosis. ( 28092276 )
2017
9
Association between long-term blood pressure control and ten-year progression in carotid arterial stiffness among hypertensive individuals: the multiethnic study of atherosclerosis. ( 28092279 )
2017
10
Chitotriosidase enzyme activity: is this a possible chronic inflammation marker in children with common variable immunodeficiency and early atherosclerosis? ( 27705887 )
2017
11
Human Neutrophil Peptide 1 Limits Hypercholesterolemia-induced Atherosclerosis by Increasing Hepatic LDL Clearance. ( 28111237 )
2017
12
Proteomic Study of Blood Serum in Coronary Atherosclerosis. ( 28091899 )
2017
13
Right Ventricular Structure and Function Are Associated With Incident Atrial Fibrillation: MESA-RV Study (Multi-Ethnic Study of Atherosclerosis-Right Ventricle). ( 28082528 )
2017
14
Postprandial Clearance of Oxidized Low-Density Lipoprotein in Patients with Stroke Due to Atherosclerosis. ( 28089094 )
2017
15
Elevated Plasma miR-29a Levels Are Associated with Increased Carotid Intima-Media Thickness in Atherosclerosis Patients. ( 28250354 )
2017
16
Ratios of leptin to insulin and adiponectin to endothelin are sex-dependently associated with extent of coronary atherosclerosis. ( 27300270 )
2017
17
Air particulate matter induced oxidative stress and inflammation in cardiovascular disease and atherosclerosis: The role of Nrf2 and AhR-mediated pathways. ( 28189649 )
2017
18
The therapeutic effect of rosuvastatin and propylthiouracil on ameliorating high-cholesterol diet-induced rabbit aortic atherosclerosis and stiffness. ( 27932239 )
2017
19
Carotid versus coronary atherosclerosis burdens in acute compared with chronic symptomatic coronary artery disease. ( 28520469 )
2017
20
Dietary intake and peripheral arterial disease incidence in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. ( 28077376 )
2017
21
Aspirin-triggered lipoxin inhibits atherosclerosis progression in ApoE(-/-) mice. ( 28071789 )
2017
22
Nuclear Factor (Erythroid-Derived 2)-Like 2 and Thioredoxin-1 in Atherosclerosis and Ischemia/Reperfusion Injury in the Heart. ( 27923281 )
2017
23
Identification of Genetic Variants Linking Protein C and Lipoprotein Metabolism: The ARIC Study (Atherosclerosis Risk in Communities). ( 28082259 )
2017
24
Molecular imaging of atherosclerosis with integrated PET imaging. ( 28078575 )
2017
25
Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis. ( 28084332 )
2017
26
Relationship between Framingham risk score and subclinical atherosclerosis in carotid plaques: an in vivo study using multi-contrast MRI. ( 28078510 )
2017
27
Association of Increased Serum Sema3E with TRIB3 Q84R Polymorphism and Carotid Atherosclerosis in Metabolic Syndrome. ( 28249916 )
2017
28
Coronary Artery Atherosclerosis in Hypertensive Patients: The Role of Fibrinogen Genetic Variability. ( 27553289 )
2017
29
Essential role of ICAM-1 in aldosterone-induced atherosclerosis. ( 28089144 )
2017
30
Paraoxonase and atherosclerosis-related cardiovascular diseases. ( 27771368 )
2017
31
Association of ADIPOQ single nucleotide polymorphisms with the risk of intracranial atherosclerosis. ( 27224208 )
2017
32
Resistin may be an independent predictor of subclinical atherosclerosis formale smokers. ( 27775434 )
2017
33
Mid-term Risk for Subclinical Atherosclerosis and Chronic Myocarditis in Children with Kawasaki Disease and Transient Coronary Abnormalities. ( 28512721 )
2017
34
Stanniocalcin-2 overexpression reduces atherosclerosis in hypercholesterolemic mice. ( 26983002 )
2016
35
Combined Effect of Hyperhomocysteinemia and Hypertension on the Presence of Early Carotid Artery Atherosclerosis. ( 26952151 )
2016
36
ORP4L Facilitates Macrophage Survival via G-Protein-Coupled Signaling: ORP4L-/- Mice Display a Reduction of Atherosclerosis. ( 27729467 )
2016
37
Subclinical Vascular Disease and Subsequent Erectile Dysfunction: The Multiethnic Study of Atherosclerosis (MESA). ( 27145089 )
2016
38
Role of long non-coding RNA-RNCR3 in atherosclerosis-related vascular dysfunction. ( 27253412 )
2016
39
Abdominal Aortic Calcification Identified on Lateral Spine Images From Bone Densitometers Are a Marker of Generalized Atherosclerosis in Elderly Women. ( 26603153 )
2016
40
OS 10-01 PREVALENCE OF CAROTID PLAQUE AND ROLE OF CARDIOVASCULAR RISK FACTORS IN A VERY ELDERLY POPULATION: ARE ATHEROSCLEROSIS AND AGING SYNONYMS? ( 27643359 )
2016
41
Calcified atherosclerosis of the pulmonary trunk, stenosis of the main pulmonary arteries, and post-stenotic dilation of segmental pulmonary arteries in a patient with Alagille syndrome. ( 27242248 )
2016
42
Neutrophil Gelatinase-Associated Lipocalin (NGAL) is Associated with Symptomatic Carotid Atherosclerosis and Drives Pro-inflammatory State InA Vitro. ( 26947538 )
2016
43
Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina. ( 26868212 )
2016
44
Serum Surfactant Protein D is Associated with Atherosclerosis of the Carotid Artery in Patients on Maintenance Hemodialysis. ( 27012038 )
2016
45
Association between the surfactant protein D (SFTPD) gene and subclinical carotid artery atherosclerosis. ( 26748346 )
2016
46
Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study. ( 27185168 )
2016
47
Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes. ( 26821950 )
2016
48
Analysis of Soluble Molecular Fibronectin-Fibrin Complexes and EDA-Fibronectin Concentration in Plasma of Patients with Atherosclerosis. ( 27022744 )
2016
49
Prenatal and early-life predictors of atopy and allergic disease in Canadian children: results of the Family Atherosclerosis Monitoring In earLY life (FAMILY) Study. ( 27453525 )
2016
50
Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis. ( 28070145 )
2016